stoxline Quote Chart Rank Option Currency Glossary
  
American Well Corporation (AMWL)
11.9  -0.26 (-2.14%)    02-18 16:00
Open: 12.16
High: 12.9501
Volume: 178,423
  
Pre. Close: 12.16
Low: 11.5
Market Cap: 186(M)
Technical analysis
2025-02-18 4:41:56 PM
Short term     
Mid term     
Targets 6-month :  15.12 1-year :  17.66
Resists First :  12.95 Second :  15.12
Pivot price 11.38
Supports First :  9.63 Second :  7.59
MAs MA(5) :  11.92 MA(20) :  11.23
MA(100) :  9.41 MA(250) :  10.47
MACD MACD :  0.7 Signal :  0.7
%K %D K(14,3) :  74 D(3) :  79.9
RSI RSI(14): 62.3
52-week High :  26.39 Low :  5
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ AMWL ] has closed below upper band by 23.8%. Bollinger Bands are 17.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 12.97 - 13.03 13.03 - 13.09
Low: 11.36 - 11.43 11.43 - 11.48
Close: 11.81 - 11.91 11.91 - 11.99
Company Description

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Headline News

Mon, 17 Feb 2025
American Well (NYSE:AMWL) Earns Hold Rating from Needham & Company LLC - MarketBeat

Sun, 16 Feb 2025
Stifel Nicolaus Forecasts Strong Price Appreciation for American Well (NYSE:AMWL) Stock - MarketBeat

Sun, 16 Feb 2025
American Well (NYSE:AMWL) Announces Earnings Results - MarketBeat

Thu, 13 Feb 2025
Amwell’s Earnings Call: Strategic Growth Amid Challenges - TipRanks

Thu, 13 Feb 2025
American Well Corporation (NYSE:AMWL) Q4 2024 Earnings Call Transcript - Insider Monkey

Thu, 13 Feb 2025
American Well Corp (AMWL) Q4 2024 Earnings Call Highlights: Strategic Gains Amidst Revenue ... - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 14 (M)
Shares Float 12 (M)
Held by Insiders 6.6 (%)
Held by Institutions 48.8 (%)
Shares Short 383 (K)
Shares Short P.Month 366 (K)
Stock Financials
EPS -13.89
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 19.56
Profit Margin -81.9 %
Operating Margin -60.3 %
Return on Assets (ttm) -26.6 %
Return on Equity (ttm) -53.5 %
Qtrly Rev. Growth 0.5 %
Gross Profit (p.s.) 7.08
Sales Per Share 18.22
EBITDA (p.s.) -13.23
Qtrly Earnings Growth 0 %
Operating Cash Flow -127 (M)
Levered Free Cash Flow -62 (M)
Stock Valuations
PE Ratio -0.86
PEG Ratio 0
Price to Book value 0.6
Price to Sales 0.65
Price to Cash Flow -1.31
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android